These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 39289750)

  • 1. Impact of an online decision support tool for ductal carcinoma in situ (DCIS) using a pre-post design (AFT-25).
    Ozanne EM; Maves K; Tramontano AC; Lynch T; Thompson A; Partridge A; Frank E; Collyar D; Basila D; Pinto D; Hyslop T; Ryser MD; Rosenberg S; Hwang ES; Punglia RS
    Breast Cancer Res; 2024 Sep; 26(1):134. PubMed ID: 39289750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A web-based personalized decision support tool for patients diagnosed with ductal carcinoma in situ: development, content evaluation, and usability testing.
    Fridman I; Chan L; Thomas J; Fish LJ; Falkovic M; Brioux J; Hunter N; Ryser DH; Hwang ES; Pollak KI; Weinfurt KP; Ryser MD
    Breast Cancer Res Treat; 2022 Apr; 192(3):517-527. PubMed ID: 35107714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment decision-making in ductal carcinoma in situ: A mixed methods systematic review of women's experiences and information needs.
    Rutherford C; Mercieca-Bebber R; Butow P; Wu JL; King MT
    Patient Educ Couns; 2017 Sep; 100(9):1654-1666. PubMed ID: 28442156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations to improve patient-centred care for ductal carcinoma in situ: Qualitative focus groups with women.
    Nyhof BB; Wright FC; Look Hong NJ; Groot G; Helyer L; Meiers P; Quan ML; Baxter NN; Urquhart R; Warburton R; Gagliardi AR
    Health Expect; 2020 Feb; 23(1):106-114. PubMed ID: 31532871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communication between patients and providers and informed decision making.
    Elmore JG; Ganschow PS; Geller BM
    J Natl Cancer Inst Monogr; 2010; 2010(41):204-9. PubMed ID: 20956831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal Carcinoma In Situ - Quo Vadis?
    Peltecu G
    Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S5-S6. PubMed ID: 34967322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
    Groen EJ; Elshof LE; Visser LL; Rutgers EJT; Winter-Warnars HAO; Lips EH; Wesseling J
    Breast; 2017 Feb; 31():274-283. PubMed ID: 27671693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying opportunities to support patient-centred care for ductal carcinoma in situ: qualitative interviews with clinicians.
    Nyhof BB; Wright FC; Look Hong NJ; Groot G; Helyer L; Meiers P; Quan ML; Baxter NN; Urquhart R; Warburton R; Gagliardi AR
    BMC Cancer; 2020 Apr; 20(1):364. PubMed ID: 32354355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. onlineDeCISion.org: a web-based decision aid for DCIS treatment.
    Ozanne EM; Schneider KH; Soeteman D; Stout N; Schrag D; Fordis M; Punglia RS
    Breast Cancer Res Treat; 2015 Nov; 154(1):181-90. PubMed ID: 26475704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What quality-of-life issues do women with ductal carcinoma in situ (DCIS) consider important when making treatment decisions?
    Mercieca-Bebber R; King MT; Boxer MM; Spillane A; Winters ZE; Butow PN; McPherson J; Rutherford C
    Breast Cancer; 2017 Sep; 24(5):720-729. PubMed ID: 28247220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.
    Martínez-Pérez C; Turnbull AK; Ekatah GE; Arthur LM; Sims AH; Thomas JS; Dixon JM
    Cancer Treat Rev; 2017 Apr; 55():163-172. PubMed ID: 28402908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a Ductal Carcinoma
    Weinmann S; Leo MC; Francisco M; Jenkins CL; Barry T; Leesman G; Linke SP; Whitworth PW; Patel R; Pellicane J; Wärnberg F; Bremer T
    Clin Cancer Res; 2020 Aug; 26(15):4054-4063. PubMed ID: 32341032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions are needed to support patient-provider decision-making for DCIS: a scoping review.
    Kim C; Liang L; Wright FC; Hong NJL; Groot G; Helyer L; Meiers P; Quan ML; Urquhart R; Warburton R; Gagliardi AR
    Breast Cancer Res Treat; 2018 Apr; 168(3):579-592. PubMed ID: 29273956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Is it cancer or not?" A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ.
    Rosenberg SM; Gierisch JM; Revette AC; Lowenstein CL; Frank ES; Collyar DE; Lynch T; Thompson AM; Partridge AH; Hwang ES
    Cancer; 2022 Apr; 128(8):1676-1683. PubMed ID: 35191017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal carcinoma in situ.
    Nakhlis F; Morrow M
    Surg Clin North Am; 2003 Aug; 83(4):821-39. PubMed ID: 12875598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT
    Shah C; Whitworth P; Vicini FA; Narod S; Gerber N; Jhawar SR; King TA; Mittendorf EA; Willey SC; Rabinovich R; Gold L; Brown E; Patel A; Vargo J; Barry PN; Rock D; Friedman N; Bedi G; Templeton S; Brown S; Gabordi R; Riley L; Lee L; Baron P; Majithia L; Mirabeau-Beale KL; Reid VJ; Hirsch A; Hwang C; Pellicane J; Maganini R; Khan S; MacDermed DM; Small W; Mittal K; Borgen P; Cox C; Shivers SC; Bremer T
    Ann Surg Oncol; 2024 Sep; 31(9):5919-5928. PubMed ID: 38916700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will oncotype DX DCIS testing guide therapy? A single-institution correlation of oncotype DX DCIS results with histopathologic findings and clinical management decisions.
    Lin CY; Mooney K; Choy W; Yang SR; Barry-Holson K; Horst K; Wapnir I; Allison K
    Mod Pathol; 2018 Apr; 31(4):562-568. PubMed ID: 29243740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (DCIS): Qualitative interview study.
    Nickel B; McCaffery K; Houssami N; Jansen J; Saunders C; Spillane A; Rutherford C; Dixon A; Barratt A; Stuart K; Robertson G; Hersch J
    Breast; 2020 Dec; 54():99-105. PubMed ID: 32971350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery and adjuvant radiotherapy for unilateral ductal carcinoma in situ (DCIS) in women aged over 70 years: A population based cohort study.
    Jauhari Y; Gannon MR; Tsang C; Horgan K; Dodwell D; Clements K; Medina J; Tang S; Pettengell R; Cromwell DA
    Eur J Surg Oncol; 2019 Aug; 45(8):1378-1387. PubMed ID: 30878169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.